Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2020 / Feb / Double Take
Microbiology & Immunology Microbiology and Immunology Guidelines and Recommendations Infectious Disease

Double Take

New figures reveal the true extent of global sepsis

By Luke Turner 02/25/2020 Quick Read (pre 2022) 1 min read

Share

The severity of sepsis is notorious. What isn’t so clear is our grasp on global statistics, which inform health policy interventions, resource allocation, and clinical treatment initiatives (1). The newly published Global Burden of Sepsis study – the most comprehensive to date on the incidence and mortality of sepsis – has revealed that true global rates are over double those previously estimated. New figures put the number of cases at 48.9 million and deaths at 11 million around the world in 2017 – a far cry from the previous global estimates of 19.4 million cases and 5.3 million deaths.

But how could previous figures fall so short? We put the question to Konrad Reinhart and Niranjan Kissoon, co-authors of the new study and President and Vice President of the Global Sepsis Alliance, respectively. “We weren’t surprised, because we knew that previous estimates were exclusively derived from high-income countries, where the number of deaths from infectious diseases is considerably lower than in low- and middle-income countries.” In fact, the previous data came from hospitalized adults in just seven high-income countries, whereas the new study analyzed 109 million death records across 195 countries between 1990 and 2017.

In 2017, an estimated 85 percent of global sepsis cases occurred in these low- and middle-income countries – and half were in children. “National action plans must include prevention strategies, such as large-scale vaccination programs – especially for children and adults in high-risk groups – against preventable infections like pneumonia, measles, common flu, and meningitis,” say Reinhart and Kissoon. The WHO designated sepsis an urgent global priority in May 2017, resolving to improve the prevention, diagnosis, and management of the deadly condition in developing countries.

However, with sepsis responsible for one in five deaths worldwide, Reinhart and Kissoon see a long road ahead: “Poor awareness among policymakers and a lack of adequate national strategies are worrying, as is the lack of education for healthcare workers and the public in terms of recognizing and treating sepsis early.”

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. KE Rudd et al., Lancet, 395, 200 (2020). PMID: 31954465.

About the Author(s)

Luke Turner

While completing my undergraduate degree in Biology, I soon discovered that my passion and strength was for writing about science rather than working in the lab. My master’s degree in Science Communication allowed me to develop my science writing skills and I was lucky enough to come to Texere Publishing straight from University. Here I am given the opportunity to write about cutting edge research and engage with leading scientists, while also being part of a fantastic team!

More Articles by Luke Turner

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Context Matters in Cancer Biology
Microbiology and Immunology
Context Matters in Cancer Biology

December 27, 2021

1 min read

Akoya is leading the way with spatial phenotypic signatures – a novel class of biomarkers for predicting response to immunotherapy

What’s New in Infectious Disease? (December 2021)
Microbiology and Immunology
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

Immunology Insights
Microbiology and Immunology
Immunology Insights

January 13, 2022

1 min read

The latest research in pathology and laboratory medicine

2021: A Laboratory Medicine Roundup
Microbiology and Immunology
2021: A Laboratory Medicine Roundup

January 18, 2022

3 min read

From transgender health care to the power of pathology podcasts, we take a look at our most popular articles of the last year

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.